Discovery of the genetic basis of a high-risk subtype of leukemia shows some patients might benefit from existing targeted therapies, advancing the goal of curing all children with the most common childhood cancer

Source: Existing drugs offer new treatment options for high-risk childhood leukemia subtype


David Cottle

UBB Owner & Administrator